LINC01088 and prostate carcinoma: Moreover, based on our observations, LINC01088 is preferentially localized in the cytoplasmic region of these cells (Figure 1(j)), implying that its effect on prostate cancer pathophysiology may be mediated by a competing endogenous RNA (ceRNA) mechanism.